Knott David M Jr
An institutional investment manager in SYOSSET, NY. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 12, 2026. SEC CIK 1892770.
- Reported value$189.2m
- Positions84
Holdings: 84 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31. The filing's table has 86 lines; lines for the same security and option type are added together here.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Alphabet Inc-Cl CGOOGL | Common | 02079K107 | 32.3 | 17.1% | 91,420 | Unchanged | |
| Apollo Global Management, Inc.APO | Common | 03769M106 | 26.6 | 14.1% | 225,000 | Unchanged | |
| Syndax Pharmaceutical, Inc.SNDX | Common | 87164F105 | 9.6 | 5.1% | 437,245 | Added+15,245 | |
| Xeris Biopharma Holdings, Inc.XERS | Common | 98422E103 | 8.4 | 4.4% | 1,060,000 | Unchanged | |
| Travere Therapeutics, Inc.TVTX | Common | 89422G107 | 8.4 | 4.4% | 147,282 | Added+6,649 | |
| Protagonist Therapeutics, IncPTGX | Common | 74366E102 | 7.7 | 4.1% | 63,000 | Unchanged | |
| Bridgebio Pharma, Inc.BBIO | Common | 10806X102 | 6.9 | 3.7% | 92,850 | Added+2,850 | |
| Iovance Biotherapeutics, Inc.IOVA | Common | 462260100 | 6.7 | 3.5% | 1,600,000 | Unchanged | |
| Alkermes PLC | Common | G01767105 | 6.4 | 3.4% | 121,759 | Added+1,759 | |
| JPMorgan Chase & Co.JPM | Common | 46625H100 | 5.9 | 3.1% | 18,098 | Reduced−1,379 | |
| Janus Henderson AAA CLO ETF | Common | 47103U845 | 4.7 | 2.5% | 93,528 | Unchanged | |
| LPL Financial Holdings Inc. | Common | 52012V100 | 4.6 | 2.5% | 16,500 | Unchanged | |
| Cogent Biosciences Inc.COGT | Common | 19240Q201 | 4.3 | 2.3% | 111,081 | Added+7,081 | |
| TG Therapeutics, Inc.TGTX | Common | 88322Q108 | 3.7 | 1.9% | 66,839 | Reduced−23,162 | |
| Catalyst Pharmaceuticals, Inc.CLST | Common | 14888L101 | 3.6 | 1.9% | 114,000 | New+114,000 | |
| Agios Pharmaceutical, Inc.AGIO | Common | 00847X104 | 3.5 | 1.9% | 95,058 | Added+2,000 | |
| Viridian Therapeutics, Inc.VRDN | Common | 92790C104 | 3.3 | 1.8% | 181,000 | Unchanged | |
| Relmada Therapeutics, Inc.RLMD | Common | 75955J402 | 3.1 | 1.6% | 451,000 | Added+11,700 | |
| Arcus Biosciences, Inc.RCUS | Common | 03969F109 | 2.5 | 1.3% | 81,241 | Unchanged | |
| Cybin Inc | Common | 23256X407 | 2.4 | 1.3% | 370,000 | Added+20,000 | |
| SPDR S&P Biotech ETF | Common | 78464A870 | 2.4 | 1.3% | 15,000 | Unchanged | |
| Rezolute, Inc.RZLT | Common | 76200L309 | 1.9 | 1.0% | 370,000 | Unchanged | |
| AllianceBernstein Holding L.P.AB | Common | 01881G106 | 1.7 | 0.9% | 48,000 | Unchanged | |
| Madrigal Pharmaaceuticals, Inc.MDGL | Common | 558868105 | 1.6 | 0.9% | 3,000 | Added+1,000 | |
| AtriCure, Inc.ATRC | Common | 04963C209 | 1.4 | 0.8% | 51,400 | Unchanged | |
| DocGo, Inc.DCGO | Common | 256086109 | 1.4 | 0.7% | 2,670,850 | Unchanged | |
| Ardelyx, Inc.ARDX | Common | 039697107 | 1.3 | 0.7% | 263,168 | Added+56,168 | |
| Ultragenyx Pharmaceutical Inc.RARE | Common | 90400D108 | 1.3 | 0.7% | 38,069 | Added+5,000 | |
| The Panagram BBB-B CLO ETF | Common | 81752T528 | 1.3 | 0.7% | 47,807 | Unchanged | |
| Cullinan Therapeutics, Inc.CGEM | Common | 230031106 | 1.3 | 0.7% | 69,182 | Added+44,982 | |
| Johnson & JohnsonJNJ | Common | 478160104 | 1.3 | 0.7% | 4,922 | Unchanged | |
| Vera Therapeutics, Inc.VERA | Common | 92337R101 | 1.1 | 0.6% | 26,000 | Unchanged | |
| Orchestra Biomed Holdings, Inc.OBIO | Common | 68572M106 | 1.1 | 0.6% | 253,651 | Unchanged | |
| Spruce Biosciences, Inc.SPRB | Common | 85209E208 | 1.1 | 0.6% | 20,000 | New+20,000 | |
| Connect Biopharma Holdings Limited | Common | G23549101 | 1.1 | 0.6% | 444,862 | Added+57,027 | |
| iShares Biotechnology ETF | Common | 464287556 | 1.0 | 0.6% | 5,500 | Unchanged | |
| Biogen Inc.BIIB | Common | 09062X103 | 0.9 | 0.5% | 4,000 | Unchanged | |
| Pfizer Inc.PFE | Common | 717081103 | 0.8 | 0.4% | 32,337 | Unchanged | |
| Apple Inc.AAPL | Common | 037833100 | 0.7 | 0.4% | 2,494 | Unchanged | |
| Canadian Natural Resources LimitedCNQ | Common | 136385101 | 0.7 | 0.4% | 16,800 | Unchanged | |
| Pelthos Therapeutics, Inc.PTHS | Common | 171126204 | 0.6 | 0.3% | 22,073 | Added+1,000 | |
| International Business MachinesIBM | Common | 459200101 | 0.6 | 0.3% | 2,142 | Unchanged | |
| Microsoft CorporationMSFT | Common | 594918104 | 0.6 | 0.3% | 1,600 | Unchanged | |
| Verastem Inc.VSTM | Common | 92337C203 | 0.6 | 0.3% | 155,000 | Added+51,000 | |
| Kura Oncology, Inc.KURA | Common | 50127T109 | 0.6 | 0.3% | 52,767 | Unchanged | |
| Solid Bioscience Inc.SLDB | Common | 83422E204 | 0.6 | 0.3% | 56,208 | Added+9,065 | |
| DuPont de Nemours, Inc. | Common | 36614N201 | 0.5 | 0.3% | 3,767 | New+3,767 | |
| Insmed IncorporatedINSM | Common | 457669307 | 0.5 | 0.2% | 4,253 | New+4,253 | |
| LB Pharmaceuticals, Inc.LBRX | Common | 50180M108 | 0.4 | 0.2% | 12,965 | New+12,965 | |
| CareDx, Inc.CDNA | Common | 14167L103 | 0.4 | 0.2% | 13,630 | New+13,630 | |
| Q32 Bio IncQTTB | Common | 746964105 | 0.4 | 0.2% | 30,412 | New+30,412 | |
| Enliven Therapeutics, Inc.ELVN | Common | 29337E102 | 0.3 | 0.2% | 6,183 | New+6,183 | |
| Ryman Hospitality Properties, Inc.RHP | Common | 78377T107 | 0.3 | 0.2% | 2,400 | Unchanged | |
| Broadcom, Inc.AVGO | Common | 11135F101 | 0.3 | 0.1% | 710 | Unchanged | |
| Kimberly-Clark CorporationKMB | Common | 494368103 | 0.3 | 0.1% | 2,400 | Unchanged | |
| Nvidia CorpNVDA | Common | 67066G104 | 0.3 | 0.1% | 1,280 | Unchanged | |
| Boston Scientific CorporationBSX | Common | 101137107 | 0.3 | 0.1% | 6,000 | New+6,000 | |
| Wave Life Science Ltd. | Common | Y95308105 | 0.2 | 0.1% | 40,000 | Unchanged | |
| Rain Enhancement Technologies Holdco IncRAIN | Common | 75080J103 | 0.2 | 0.1% | 101,686 | Unchanged | |
| Mondelez International, Inc.MDLZ | Common | 609207105 | 0.2 | <0.1% | 3,000 | Unchanged | |
| Quanta Services, Inc.PWR | Common | 74762E102 | 0.1 | <0.1% | 176 | Unchanged | |
| Bristol-Myers Squibb CompanyBMY | Common | 110122108 | 0.1 | <0.1% | 2,000 | Reduced−11,622 | |
| Eastern Bankshares IncEBC | Common | 27627N105 | 0.1 | <0.1% | 5,000 | Unchanged | |
| Alphabet Inc CL AGOOGL | Common | 02079K305 | 0.1 | <0.1% | 300 | Unchanged | |
| Legacy Housing CorporationLEGH | Common | 52472M101 | 0.1 | <0.1% | 4,000 | Unchanged | |
| Corteva, Inc.CTVA | Common | 22052L104 | 0.1 | <0.1% | 1,206 | Unchanged | |
| iShares Russell Mid-Cap Growth | Common | 464287481 | 0.1 | <0.1% | 695 | Unchanged | |
| United Rental, Inc.URI | Common | 911363109 | 0.1 | <0.1% | 78 | Unchanged | |
| Invivyd, Inc.IVVD | Common | 00534A102 | 0.1 | <0.1% | 100,000 | Unchanged | |
| Amazon.com Inc.AMZN | Common | 023135106 | 0.1 | <0.1% | 300 | Unchanged | |
| Danaher CorporationDHR | Common | 235851102 | 0.0 | <0.1% | 180 | Unchanged | |
| Dow Inc.DOW | Common | 260557103 | 0.0 | <0.1% | 1,206 | Unchanged | |
| FS KKR Capital Corp.FSK | Common | 302635206 | 0.0 | <0.1% | 2,875 | New+2,875 | |
| International Game Technology PLC | Common | G4863A108 | 0.0 | <0.1% | 2,500 | Unchanged | |
| Blackstone Group LPBX | Common | 09260D107 | 0.0 | <0.1% | 210 | Unchanged | |
| United Healthcare Corp.UNH | Common | 91324P102 | 0.0 | <0.1% | 57 | Unchanged | |
| Occidental Petroleum CorporationOXY | Common | 674599105 | 0.0 | <0.1% | 469 | Reduced−194 | |
| Thermo Fisher Scientific, Inc.TMO | Common | 883556102 | 0.0 | <0.1% | 45 | Unchanged | |
| Salesforce, Inc.CRM | Common | 79466L302 | 0.0 | <0.1% | 77 | Unchanged | |
| Starwood Property Trust, Inc.STWD | Common | 85571B105 | 0.0 | <0.1% | 400 | Unchanged | |
| Kyndryl Holdings Inc.KD | Common | 50155Q100 | 0.0 | <0.1% | 428 | Unchanged | |
| Occidential Pertro Wts exp. 8/3/27 | Common | 674599162 | 0.0 | <0.1% | 194 | New+194 | |
| GE HealthCare Technologies IncGEHC | Common | 36266G107 | 0.0 | <0.1% | 50 | Unchanged | |
| Wabtec CorporationWAB | Common | 929740108 | 0.0 | <0.1% | 6 | Unchanged |
Sold out: 12 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| ADMA Biologics, Inc.ADMA | Common | 000899104 | 0.0 | 0.0% | 0 | Sold out−60,200 | |
| Arcellx Inc | Common | 03940C100 | 0.0 | 0.0% | 0 | Sold out−19,433 | |
| Biohaven Pharmaceutical Holding Co. Ltd | Common | G111OE107 | 0.0 | 0.0% | 0 | Sold out−60,720 | |
| Catalyst Pharmaceuticals, Inc. | Common | 14888U101 | 0.0 | 0.0% | 0 | Sold out−120,000 | |
| Centessa Pharmaceuticals PLC | Common | 152309100 | 0.0 | 0.0% | 0 | Sold out−39,000 | |
| Cytokinetics, IncorporatedCYTK | Common | 23282W605 | 0.0 | 0.0% | 0 | Sold out−23,644 | |
| DuPont de Nemours, Inc. | Common | 26614N102 | 0.0 | 0.0% | 0 | Sold out−3,767 | |
| Evolus, Inc.EOLS | Common | 30052C107 | 0.0 | 0.0% | 0 | Sold out−99,338 | |
| FS KKR Capital Corp. | Common | 302635107 | 0.0 | 0.0% | 0 | Sold out−2,875 | |
| Jasper Therapeutics, Inc.JSPR | Common | 471871202 | 0.0 | 0.0% | 0 | Sold out−160,789 | |
| LENZ Therapeutics, Inc.LENZ | Common | 52635N103 | 0.0 | 0.0% | 0 | Sold out−33,732 | |
| Mereo BioPharm Group PLCMREO | Common | 589492107 | 0.0 | 0.0% | 0 | Sold out−300,337 |
Source: SEC EDGAR, Form 13F-HR, accession 0001104659-26-094536 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.